Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S14 pseudogene 7 (RPS14P7) is a processed pseudogene and does not encode a functional protein product[2][5][8]. It is derived from the ribosomal protein S14 gene (RPS14), a critical component of the small (40S) ribosomal subunit involved in protein synthesis[1][4][10], but RPS14P7 itself has no known protein-coding function or direct biological activity. Like many pseudogenes, it is present in the genome but is generally considered non-functional and does not participate in canonical pathways or serve as a therapeutic target. No disease associations, interacting drugs, or recognized biomarker value have been attributed to RPS14P7. The presence of the "pseudogene" designation and lack of coding potential mean it is not considered a genuine molecular target in drug discovery or biology[2][5][8]. RPS14P7 (Ribosomal protein S14 pseudogene 7) is not a protein-coding gene and does not represent a functional molecule suitable as a drug target[2][5][8]. It should not be included in therapeutic target databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S14 pseudogene 7 (RPS14P7).